Interleukin-18: A proinflammatory cytokine in HIV-1 infection

Current HIV Research

Volumn 4, Issue 4, 2006, Pages 423-430

  Torre, Donato ^a   Pugliese, Agostino ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

AIDS; Gamma interferon; HIV 1 infection; Interleukin 12; Interleukin 18; Interleukin 18 binding protein

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 2;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; INNATE IMMUNITY; INSULIN RESISTANCE; LIPODYSTROPHY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; TH1 CELL; TH2 CELL; VIRUS REPLICATION;

ANIMALS; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR;

EID: 33749527367     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016206778559993     Document Type: Review

References (78)

1. Ahmad R, Sindhu STA, Toma E, Morisset R, Ahmad A. (2002). Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis. Journal of Virology. 76: 12448-12456.
2. Aso Y, Okumara K, Takebayashi K, Wakabayashi S, Inukai T. (2003). Relationship of plasma interleukin-18 concentrations to hyperomocysteinemia and carotid intimal-median wall thickeness in patients with type 2 diabetes. Diabetes Care. 26: 2622-2627.
3. Banchereau J, Briere F, Caux C, Davoust j, Lebecque S, Liu YJ, Pulendran B, Palucka K. (2000). Immunobiology of dendritic cells. Annual Review of Immunology. 18: 767-797.
4. Blakenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ. (2002). Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 106: 24-28.
5. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. (1998). A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 12: F51-F58.
6. Chambers KA, Parato KG, Angel JB. (2002). Active cellular infection of myeloid cells is required for HIV-1-mediated suppression of interleukin-12 p40 expression. Cellular Immunology. 215: 120-132.
7. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, Mac Gregor RR, Sennelier J, Trinchieri G. (1994). Impaired IL-12 production in human immunodeficiency virus-infected patients. Journal of Experimental Medicine. 179: 1361-1368.
8. Chantry D, Turer M, Akney E, Feldmann M. (1988). Modulation of cytokine production by transforming growth factor-beta. Journal of Immunology. 142: 4295-4300.
9. Choi HJ, Dinarello CA, Shapiro L. (2001). Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. Journal of Infectious Diseases. 184: 560-568.
10. Choi HJ, Dinarello CA, Shapiro L. (2002). Role of interleukin-18 in human immunodeficiency virus type 1 infection. (Reply) Journal of Infectious Diseases. 185: 998-999.
11. Chaisavaneeyakorn S, Moore JM, Otieno J,. (2002). Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women. Journal of Infectious Diseases. 185: 127-131.
12. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM. (1993). Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-positive individuals. Journal of Clinical Investigation. 91: 759-765.
13. Constans J, Marchand JM, Conri C, Peuchant E, Seigneur M, Rispal P, Lasseur C, Pellegrin JL, Leng B. (1995). Asymptomatic atherosclerosis in HIV-positive patients: a case-control ultrasound study. Annals of Medicine. 27: 683-685.
14. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, Laharrague M. (1999). A role for preadipocytes as macrophage-like cells. FASEB Journal 13:305-312.
15. David D, Chevrier D, Treilhou MP, Joussemet M, Dupont B, Theze J, Guesdon JL. (2000). IL-18 underexpression reduces IL-2 levels during HIV infection: a critical step towards the faulty cell-mediated immunity? AIDS. 2000; 14:2212-2213.
16. Domingo P, Matias-Guiu X, Pujol RM, Francia E, Lagarda E, Sambeat MA, Vazquez G. (1999). Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS. 13: 2261-2267.
17. Esposito K, Pontillo A, Ciotola M, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. (2003). Weight loss reduces interleukin-18 levels in obese women. Journal of Clinical and Endocrinological Metabolism. 87:3864-3866.
18. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Paolisso G. (2003). Cytokine milieu tends towards inflammation in type 2 diabetes. Diabetes Care. 26:1647-1651.
19. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D. (2003). Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. American Journal of Clinical Nutrition. 78:1135-1140.
20. Falasca K, Manigrasso MR, Racciatti D, Zingariello P, D'Alessandro M, Ucciferri C, Mancino P, Marinopiccoli M, Petrarca C, Conti P, Pizzigallo E, Guagnano MT, Vecchiet J. (2006). Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and interleukin-18 levels in HIV-infected patients. Annals of Clinical Laboratory Science. 36:59-66.
21. Feldman S, Stein D, Amrute S, Denny T, Garcia Z, Kloser P. (2001). Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clinical Immunology. 101:201-210.
22. Ferbas JJ, Toso JF, Logar AJ, Navratil JS, Rinaldo CR. (1994). CD4 blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. Journal of Immunology. 152: 4649-4662.
23. Ferbas J, Navratil J, Logar A, Rinaldo C. (1995). Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection. Clinical Diagnostic and Laboratory Immunology. 2:138-142.
24. Gardella S, Andrei C, Costigliolo S, Zocchi MR, Rubartelli A. (1999). Interleukin-18 synthesis and secretion by dendritic cells are modulated by interaction with antigen-specific T cells. Journal of Leukocyte Biology. 66:237-241.
25. Gherardi MM, Ramirez JC, Esteban M. (2003). IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system. Journal of General Virology. 84:1961-1972.
26. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. (2002) Expression of interleukin(IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. Journal of Experimental Medicine. 195:245-251.
27. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL. (2002). Expression of IL-18 by SIV does not modify the outcome of the antiviral immune response. Virology. 303:327-337.
28. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL. (2000). Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. Journal of Virology. 74:1648-1657.
29. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimono M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingstone DJ, SU MSS. (1997). Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science. 275:206-209.
30. Hadigan C, Miller K, Corcoran C, Anderson E, Basgoz N, Grinspoon S. (1999). Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. Journal of Clinical and Endocrinological Metabolism. 84: 1932-19377.
31. Hammond E, Nolan D, McKinnon E, Pace C, Metcalf C, Mammal S. (2005). Assessing the contribution of ART, HIV and host factors to adipose tissue changes occurring in HIV-infected individuals: risk profile for lipoatrophy. 7th International Workshop on adverse events and lipodystrophy in HIV; November 13-16, 2005; Dubli, Ireland. Abstarct 2.
32. He L, Terunuma H, Hanabusa H, Iwamoto A, Oka S, Tanabe F, Chiba N, Kurimoto M, Ikeda M, Okamura H, Dai J, Iwatani Y, Ishida T, Ito M. (2000). Interleukin 18 and interleukin 1 beta production is decreased in HIV type 1-seropositive hemophiliacs but not in HIV type 1-seropositive nonhemophiliacs. AIDS Research and Human Retroviruses. 16:345-353.
33. Jiang C, Ting AT, Seed B. (1998). PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:82-86.
34. Kaizu M, Ami Y, Nakasone T, Sasaki Y, Izumi Y, Sato H, Takahashi E, Sakai K, Shinohara K, Nakanishi K, Honda M. (2003). Higher levels of IL-18 circulate during primary infection of monkeys with a pathogenic SHIV than with a nonpathogenic SHIV. Virology. 313:8-12.
35. Kaser A, Kaser S, Kaneider NC, Enrich B, Wiedermann CJ, Tilg H. (2004). Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood. 103:648-655.
36. Kashiwamura S, Ueda H, Okamura H. (2002). Roles of interleukin-18 in tissue destruction and compensatoory reactions. Journal of Immunotherapy. 25 (Suppl. 1):S4-S11.
37. Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA. (2000). Structural requirements of six naturally occurring isoforms of the interleukin-18 binding protein to inhibit interleukin-18. Proceedings of National Academy of Sciences United States of America. 97:1190-1195.
38. Kotler DP, Ionescu G, Johnson JA, Inada Y, He Q, Engelson ES, Albu JB. (2003). Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy. Clinical Infectious Diseases. 37 (Suppl. 2):S47-S51.
39. Lindegaard B, Hansen ABE, Pilegaard H, Keller P, Gerstoft J, Pedersen BK. (2004). Adipose tissue expression of IL-18 anf HIV-associated lipodystrophy. AIDS. 18:1956-1958.
40. Lindegaard B, Hansen ABE, Gerstoft J, Pedersen BK. (2004). High plasma levels of interleukin-18 in HIV-infected subjects with lipodystrophy. Journal of Acquired Immune Deficiency Syndrome. 36:588-593.
41. Ma X, Montaner LJ. (2000). Proinflammatory response and IL-12 expression in HIV-1 infection. Journal of Leukocyte Biology. 68: 383-390.
42. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A. (2001). Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 104:1598-1603.
43. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. (2001). Interleukin-18/ interleukin-18 binding protein signalling modulates atherosclerosis lesion development and stability. Circulation Research. 98: E41-E46.
44. Malmgaard L, Paludan SR. (2003). Interferon (IFN)-alpha/beta, interleukin(IL)-12 and IL-18 coordinately induce production of gamma IFN during infection with herpes simplex virus type 2. Journal of General Virology. 84:2497-2500.
45. Medzhitov R, Janeway C Jr. (2000). Innate immunity. New England Journal of Medicine. 343:338-344.
46. Merrill JE, Koyanagi Y, Chen IS. (1989). Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by HIV type 1 binding to the CD4 receptor. Journal of Virology. 63:4404-4408.
47. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annual Review of Immunology. 19:423-474.
48. Nakajima, K, Martinez-Maza O, Hirano T, Breen EC, Nishanian PG, Salazar-Gonzales JF, Fahey JL, Kishimoto T. (1989). Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. Journal of Immunology. 142:531-536.
49. Novick D, Kim SH, Fantuzzi G, Reznikov L, Dinarello CA, Rubinstein M. (1999). Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 10:127-136.
50. Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim SH, Fantuzzi G, Dinarello CA, Rubinstein M. (2001). A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine. 14:334-342.
51. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K. (1995). Cloning of a new cytokine that induces gamma IFN production by T cells. Nature. 378:88-91.
52. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S. (1995). A novel costimulatory factor for gamma interferon induction found in the liver of mice causes endotoxic shock. Infection and Immunity. 63: 3966-3972.
53. Olusi SO, Al-Awadhi A, Abraham M. (2003). Relations of serum interleukin 18 levels to serum lipid and glucose concentrations in an apparently adult population. Hormone Research. 60: 29-33.
54. Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. (2002). A unique mechanism for innate cytokine promotion of T cell responses to viral infections. Journal of Immunology. 169: 5827-5837.
55. Pirhonen J. (2001). Regulation of IL-18 expression in virus infection. Scandinavian Journal of Immunology. 53: 533-539.
56. Poli G. (1999). Cytokines and the human immunodeficiency virus: from bench to bedside. European Journal of Clinical Investigation. 29: 723-732.
57. Pugliese A, Gennero L, Vidotto V, Speranza F, Tambini R, Torre D. (2002). Interleukin-18 enhances HIV-1 production in a human chronically-infected T cell line (H9-V). Cell Biochemestry and Function. 20: 333-337.
58. Ramsay AJ, Ruby J, Ramshaw IA. (1993). A case for cytokines as effector molecules in the resolution of virus infection. Immunology Today. 14: 155-157.
59. Reading PC, Smith GL. (2003). Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. Journal of Virology. 77: 9960-9968.
60. Senpuku H, Asano T, Matin K, Abdus Salam M, Tsuha Y, Horibata S, Shimazu Y, Soeno Y, Aoba T, Sata T, Hanada N, Honda M. (2002). Effects of human interleukin-18 and interleukin-12 treatment on human lymphocyte engrafment in NOD-scid mouse. Immunology. 107: 232-242.
61. Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Shenkar R, Gu Y, Su MS, Dinarello CA. (2000). Interleukin-18 stimulates HIV-1 replication in a T cell line. European Cytokine Network. 11: 47-52.
62. Shearer GM. (1998). HIV-induced immunopathogenesis. Immunity. 9: 587-593.
63. Song W, Wilson CM, Allen S, Wang C, Li Y, Kaslow RA, Tang J. (2006). Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults. Clinical and Experimental Immunology. 144: 117-124.
64. Stein JH. (2005). Managing cardiovascular risk in patients with HIV infection. Journal of Acquired Immune Deficiency Syndrome. 38: 115-123.
65. Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Damas JK, Aukrust P, Froland SS. (2003). Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients. Clinical Experimental Immunology. 132: 462-466.
66. Tabib A, Greenland T, Mercier I, Loire R, Mornex JF. (1992). Coronary lesions in young HIV-positive subjects at necroscopy. Lancet. 340: 730.
67. Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C. (2005). Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetes. 54: 2932-8.
68. Torre D, Speranza F, Martegani R, Pugliese A, Castelli F, Basilico C, Biondi G. (2000). Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection. AIDS. 14: 2211-2212.
69. Wood IS, Wang B, Jenkins JR, Trayhurn P. (2005). The proinflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNF alpha in human adipocytes. Biochemical and Biophysical Research Communications. 337: 422-429.
70. Xiang Y, Moss B. (1999). IL-18 binding and inhibition of interferon gamma induction by human poxvirus encoded proteins. Proceedings of National Academy of Sciences United States of America. 96: 11537-11543.
71. Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold CM. (1997). TNT-alpha-mediated inhibition and reversal of adipocyte differentiation is accompained by suppressed expression of PPAR gamma without effects on Pref-1 expression. Endocrinology. 138: 2776-2783.
72. Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, Nagai Y, Hori M. (2005). Associations of serum IL-18 levels with carotid intima-media thickness. Arteriosclerosis and Thrombosis and Vascular Biology. 25: 1458-1462.
73. Yamashita H, Shimada K, Seki E, Mokuno H, Daida H. (2003). Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. American Journal of Cardiology. 91: 133-139.
74. Yamaoka-Tojo M, Tojo T, Masuda T, Machida Y, Kitano Y, Kurosawa T, Izumi T. (2003). C-reactive protein-induced production of IL-18 in human endothelial cells: mechanisms of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels. 18: 183-188.
75. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K.(1998) IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for gamma IFN production. Journal of Immunology. 161: 3400-3407.
76. Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, Izumi S, Okamura H, Paul WE, Nakanishi K. (2000). IL-18 induction of IgE: dependence on CD4 T cells, IL-4 and STAT6. Nature Immunology. 1: 132-137.
77. Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, Moller DE. (1996). Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Molecular Endocrinology. 10: 1457-1466.
78. Zinkernagel RM. (1996). Immunology taught by viruses. Science. 271: 173-178.